Member Info for stephen11

Joking of course - yes - we must have hit the resistance level.

Fibonacci - does he not play left-back for Inter Milan?

Agree with posts below - GDR should be aggressively marketing the POC. We should all be asking them this:

As the pandemic shifts to an endemic, marked by Prime Minister Boris Johnson announcing plans for how the country can begin ‘Living with Covid,’ lateral flow and PCR tests will no longer be free. With official testing data showing that over 900,000 tests are taken a day, what is GDR doing to aggressively market the new COVID POC test to the private and public sector in the UK, prior to UKCTDA approval?

This is a massive, massive opportunity.

GLA.

Anyone else thinking of posting some questions for the presentation on Thursday week? I think the more we challenge them with pertinent points the better. I detail one below:

As the pandemic shifts to an endemic, marked by Prime Minister Boris Johnson announcing plans for how the country can begin ‘Living with Covid,’ lateral flow and PCR tests will no longer be free. With official testing data showing that over 900,000 tests are taken a day, what is GDR doing to aggressively market the new COVID POC test to the private and public sector in the UK, prior to UKCTDA approval?

This is a massive, massive opportunity.

GLA.

Great find Jimi,

It's great that eagle eyed investors find gems of information like this, but a shame GDR don't update shareholders more on such matters! Or might this be included in the Investor Meet Company Presentation on the 31st March? This amount is not to be sneezed at.

GLA.

Anyone else wanting to wait to the start of the new tax year on April 6th before top slicing, to delay a big bill until January 2023?

Hopefully the PALOH study will have been published and UK accreditation of the POC will have landed by then - in an ideal world (along with all the other great news pending)!

GLA.

Agree - ref…long term holding. I might topslice from my HL account at some point and leave my ISA shares to go on a free run. The new technology used in the hearing loss product is replicable in other medical areas and is world leading.

GLA.

I am genuinely pleased for all the long term holders out their. Make sure to enjoy your favourite tipple tonight.

I would draw your attention to one part of todays RNS, as below:

The Genedrive MT-RNR1 System is available in the UK and Ireland in cooperation with Inspiration Healthcare (AIM: IHC). Hospitals interested in discovering more about how to manage ototoxicity can visit

https://www.genedrive.com/assays/rnr1-product.php.

There are currently 1,229 NHS hospitals in the UK, spread amongst 225 trusts, and 86 hospitals in Southern Ireland. Let's also not discount the growing number of opportunities from private hospitals.

Then their is the PALOH journal article, UK POC validation, and associated sales to look forward too.

GLA.

Ps...BigAl...i fear the rocket may need some maintenance work over the weekend, after today and in preparation for Monday morning, though i am confident you are the man for the job!

If this gets above 20p today i might have to crack open the white wine early tonight.

20p would be a good base to hit before news on multiple fronts hit.

GLA.

Jay,

Your constant whingeing is becoming annoying. If you believe GDR is such a bad share with no prospects then why don’t you sell up and look for more lucrative opportunities elsewhere.

Stephen11.

Australian preterm babies per year - around 310, 000
Worldwide preterm babies per year - around 15 million

This is a gap in the market with a market in the gap!

Wow - great find and very nice to hear of interest from America, who have around 380,000 babies per year born prematurely (around a tenth of all births)

As below:

https://uk.yahoo.com/news/covid-not-yet-seasonal-predictable-172902986.html

I love your optimism Raffs60, but we need to keep things realistic.

It took 10 months for Novacyt to bounce from around 15p in January 2020 to the high you mention (of over £12.00 in late October 2020).

Let's try to get GDR to £1.00 again first, to get all the long-term holders above water again and then see were things go.

I think £1.50-£2.00 is possible this year, if we land all the promised developments. Plus actual sales orders/revenue of course.

GLA.

Stephen11.

Think about this, it could be a win-win for GDR, providing the POC test gets UK validation.

Many companies and organisations will have a need for accurate testing. Let’s hope they buy GDRs superior POC test and not those inaccurate Chinese LFTs.

GLA.

Stephen11.

Good points and well articulated Tricky - queue imaginary thumbs up!

GDR could be in the middle of a perfect storm at the moment and ready to help on the multiple fronts you describe.

GLA.

Good Man BigAl,

I knew you could be relied upon to keep the spaceship well maintained.

On actual news this will fly!!!!!!!!!!!!!

She's going to blow

The rocket is about to take off!

I hope we get to 20p before news, then the sky is the limit with UK POC news, EU orders, Hearing loss study, and launch all imminent.

GLA

Stephen11.

As below:

https://uk.yahoo.com/news/one-25-england-covid-cases-113113554.html